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Abstract
Although retroviruses have been extensively studied for many years, basic questions about how retroviral infections are
detected by the immune system and which innate pathways are required for the generation of immune responses remain
unanswered. Defining these pathways and how they contribute to the anti-retroviral immune responses would assist in the
development of more effective vaccines for retroviral pathogens such as HIV. We have investigated the roles played by
CD11c
+ dendritic cells (DCs) and by Toll-like receptor (TLR) signaling pathways in the generation of an anti-retroviral
immune response against a mouse retroviral pathogen, Friend murine leukemia virus (F-MLV). Specific deletion of DCs
during F-MLV infection caused a significant increase in viral titers at 14 days post-infection, indicating the importance of DCs
in immune control of the infection. Similarly, Myd88 knockout mice failed to control F-MLV, and sustained high viral titers
(10
7 foci/spleen) for several months after infection. Strikingly, both DC-depleted mice and Myd88 knockout mice exhibited
only a partial reduction of CD8
+ T cell responses, while the IgG antibody response to F-MLV was completely lost.
Furthermore, passive transfer of immune serum from wild-type mice to Myd88 knockout mice rescued control of F-MLV.
These results identify TLR signaling and CD11c
+ DCs as playing critical roles in the humoral response to retroviruses.
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Introduction
The HIV pandemic has spurred intensive research into
retroviruses, and yet an effective vaccine for HIV has remained
elusive. Acute HIV infection stimulates both B and T cell
responses, but the antibody response is ineffective, possibly due
to shielding of neutralizing epitopes [1,2]. By contrast, HIV-
specific CD8
+ T cells are able to control infection early on, but
become progressively less effective during the chronic phase of
infection due to mechanisms that remain unclear [3,4]. Vaccines
designed to stimulate protective B cell or T cell responses have
been used in clinical trials, but have been unsuccessful at either
preventing infection or reducing viral titers in infected individuals
[5]. Thus, a more fundamental understanding of anti-retroviral
immune responses is needed to develop an effective vaccine. Basic
questions that have not been answered include: 1) Which antigen
presenting cell populations are necessary or sufficient to generate
an immune response? 2) Which innate signaling pathways detect
retroviral infection in vivo and are responsible for initiating
adaptive immune responses?
There have been major advances during the past decade in our
understanding of how the innate immune system functions to limit
viral growth and stimulate T and B cell- dependent adaptive
immune responses. It is now understood that microbial products
that serve as pathogen-associated molecular patterns (PAMPs) are
detected by germline-encoded innate immune receptors, such as
the members of the Toll-like receptor (TLR) family [6]. These
receptors are prominently expressed in antigen-presenting cells
such as dendritic cells (DCs) that function at the interface between
innate and adaptive immunity. Humans encode at least ten TLRs
while mice encode at least twelve. Products of bacterial metabolic
pathways are recognized by specific TLRs such as LPS by TLR4
and flagellin by TLR5 [7]. Viruses, by contrast, are thought to be
detected by mechanisms that involve endosomal localization of
viral nucleic acids. ssRNA is detected by TLR7 [8,9], dsRNA is
detected by TLR3 [10], and CpG dsDNA is recognized by TLR9
[11]. All TLRs except for TLR3 signal through a pathway that
involves the adaptor Myd88 [12]. Upon stimulation, Myd88 is
recruited to the TLR as a dimer, and activates the kinases IRAK1
and IRAK4. This activates a signaling cascade that ultimately
leads to the activation of the pro-inflammatory transcription factor
NF-kB, as well as the MAP kinase and JNK pathways [13]. In the
absence of Myd88, TLR3 and TLR4 are able to signal through
another adaptor, TRIF [14].
Friend murine leukemia virus (F-MLV) is a complex gamma-
retrovirus that has been used to understand basic principles of
anti-retroviral immune responses and mechanisms of chronic
infection [15]. It consists of a replication-competent helper virus
and a replication-defective spleen focus-forming virus (SFFV).
SFFV encodes a protein, gp55, which binds to the erythropoietin
receptor and causes hyper-proliferation of erythroid precursors
and splenomegaly. The susceptibility of mice to F-MLV is affected
by a number of host genes. In mouse strains such as Balb/c,
immune responses are ineffective and sustained high virus titers
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infection is controlled by CD8
+ T cells and neutralizing antibodies,
but the virus is not completely cleared and establishes a low level
persistent infection [16].
Retroviral particles for HIV and F-MLV possess potential TLR
ligands, and could conceivably be detected by TLR signaling [17].
Indeed, some evidence has indicated that plasmacytoid dendritic
cells secrete type I interferons in response to HIV by way of a
TLR7-dependent pathway [18]. However, the role played by
TLRs in generating an anti-retroviral immune response in vivo is
unknown.
In this study, we addressed the roles played by CDllc
+ DCs and
Myd88-dependent signaling in the immune response to F-MLV
infection in vivo. Using mice that permit specific deletion of
CD11c
+ DCs as well as Myd88-deficient mice, we determined that
DCs and Myd88 contribute to, but are not required for, T cell
responses to F-MLV, but are absolutely required for the
generation of virus-neutralizing antibodies.
Results
F-MLV replication kinetics in vivo
Previous reports demonstrated that F-MLV titers in the spleens
of infected mice peak at 14 days post-infection (dpi) before they
subside to a low level during the phase of chronic infection.
However, F-MLV stocks used in the earlier studies were
contaminated with Lactate Dehydrogenase-Elevating Virus
(LDV), which has been shown to delay the immune response to
F-MLV [19]. To establish growth kinetics of F-MLV in vivo in the
absence of LDV, we infected C57BL/6 mice with F-MLV and
measured viral titers in the spleen at different times post-infection.
The number of foci per spleen peaked around 7 dpi at
approximately 10
6 foci per spleen, and by 14 dpi the viral titer
had been reduced to between 10
2 and 10
3 foci per spleen
(Figure 1). This growth curve is consistent with a recent report
using LDV-free F-MLV [19].
F-MLV infection causes dendritic cell maturation in vivo
Dendritic cells (DCs) are specialized cells that carry out a
number of important roles. They detect pathogens through innate
receptors and activate signaling pathways that lead to the
expression of cytokines. Furthermore, they present foreign
antigens to T cells by way of MHCI and MHCII molecules.
Mouse splenic DCs consist of three major subsets with specialized
functions. CDllc
+ CD8a
2 B220
2 (‘‘myeloid’’) DCs are the
classical antigen-presenting cell and are important for activation
of CD4
+ T cells. CDllc
Int B220
+ CD8a
2 (‘‘plasmacytoid’’) DCs
are potent producers of type 1 interferons [20]. CDllc
+ B220
2
CD8a
+ DCs are specialized for cross presentation and are
important for activating CD8
+ T cells [21]. When DCs detect
foreign pathogens they mature and up-regulate their antigen
presenting machinery as well as costimulatory molecules such as
CD80 and CD86. To determine if F-MLV causes activation of
specific DC subsets during infection, we infected C57BL/6 mice
with F-MLV and examined the expression of CD80 and CD86 on
all three splenic DC subsets at different times post-infection. CD80
and CD86 were upregulated on all three DC subsets beginning at
7 dpi (Figure 2). DC expression of CD80 and CD86 levels
returned to baseline by 14 dpi. This indicates that all three DC
subsets mature in response to F-MLV infection in vivo, and that
DC activation peaks between 7–10 dpi.
DCs are required for control of F-MLV replication
Immune control of F-MLV requires both CD8
+ cytotoxic T
lymphocyte (CTL) and neutralizing antibody responses [22].
Several cell types, including DCs, macrophages and B cells, are
capable of antigen presentation to T cells, but for most pathogens
it is unclear which of these cell types is explicitly required for the
generation of specific immune responses. To investigate the role of
CD11c
+ DCs in immune function, we previously developed
transgenic mice that express the diphtheria toxin receptor (DTR)
under the control of the CD11c promoter [23]. Since expression of
DTR renders murine cells susceptible to killing by diphtheria toxin
(DT), this transgene allows for specific deletion of CDllc-expressing
DCs in vivo by the administration of DT. Because repeated
administration of DT to these mice is lethal within 7 days due to
an unknown mechanism, we generated bone marrow chimeras, by
lethally irradiating C57BL/6 mice and reconstituting them with
wild-type or CDllc-DTR transgenic bone marrow. Mice receiving
the transgenic bone marrow are viable through at least 2 weeks of
repeated DT injection.
To investigate the role played by CD11c
+ DCs in the immune
response to a retrovirus, we infected the chimeric mice with F-
MLV. To delete DCs, we injected 200 ng DT daily from one day
prior to infection until 14 dpi. At 14 dpi, the mice were sacrificed,
and the extent of DC depletion in the spleen was determined by
flow cytometry. Deletion of CD11c
+ cells was typically around
Figure 1. F-MLV growth curve in vivo. C57BL/6 mice were infected
with F-MLV. At the time indicated, the number of viral foci in the spleen
was measured by focus-forming assay on Mus Dunni cells. Each bar
represents the average of five mice. The data shown are representative
of two independent experiments.
doi:10.1371/journal.ppat.1000298.g001
Author Summary
Efforts to develop vaccines against the retrovirus HIV by
inducing immune responses involving antibodies or T cells
have been unsuccessful. Although antibodies can be
generated against HIV, they fail to neutralize the virus.
Thus, a more fundamental understanding of how neutral-
izing antibody responses to retroviral pathogens are
generated is required. We have used a mouse retrovirus
to demonstrate that Myd88, a molecule centrally involved
in innate immune system signaling, is required to generate
an antibody response during retroviral infection. Myd88
also contributed to, but was not strictly required for, the T
cell response. Myd88 is known to participate in a signaling
pathway that activates inflammation in response to
microbial molecules. Understanding how this pathway
contributes to anti-retroviral antibody responses may be
useful for the development of a vaccine that can
effectively block HIV.
Myd88 Is Required for Anti-Retroviral Antibodies
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spleens of DC-depleted mice was 100-fold higher than in non-
depleted mice (Figure 3B, left panel). This indicates that CDllc
+
DCs play an essential role in immune control of F-MLV, and that
other antigen presenting cells are not sufficient for full activation of
anti-retroviral immune responses. DC-depleted mice also exhib-
ited increased splenomegaly (Figure 3B, right panel), indicative of
higher levels of virus.
To learn about the temporal requirement for DCs in immune
control of F-MLV infection, we also depleted DCs from day 4 to
14 following infection. We had previously observed strong
activation of DC populations in the spleen at 7–10 dpi (Figure 2).
Interestingly, depletion from day 4–14 post-infection did not result
in a significant increase in virus titers in the spleen relative to
undepleted mice (not shown). This suggests that the presence of
DCs during the first four days of infection is sufficient to establish
Figure 2. F-MLV infection causes dendritic cell maturation in vivo. C57BL/6 mice were infected with F-MLV. At the times indicated, dendritic
cell populations in the spleen were analyzed for maturation by staining for CD80 and CD86. Each FACS plot is representative of five mice. Data from
uninfected mice are shown in red, while infected mice are shown in blue. The data shown are representative of three independent experiments.
doi:10.1371/journal.ppat.1000298.g002
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in infection are not required.
DCs are required for the neutralizing antibody response
to F-MLV
Since DC-depleted mice exhibited reduced ability to control F-
MLV, we wished to determine whether either the CTL or
neutralizing antibody response was affected by the depletion. To
measure the role of CD11c
+ DCs in the CTL response, we
infected chimeras reconstituted with wild-type or CDllc-DTR
bone marrow with F-MLV. DCs were depleted by injection of DT
from one day prior to infection until 14 days post-infection. At 14
dpi, splenocytes were stained with the D
b-GagL tetramer. This
tetramer typically stains 5–10% of CD8
+ CTLs in a F-MLV–
infected wild-type mouse, but does not stain CD8
+ T cells from
naı ¨ve mice [16]. We found that the proportion of CD8
+ T cells
that stained with D
b-GagL was only slightly reduced in DC-
depleted mice, suggesting that high levels of CD11c
+ DCs are not
required for the generation of CTL responses to F-MLV
(Figure 4A). It is possible that only a small number of DCs is
sufficient for activating a CD8
+ T cell responses, or that a non-
depleted APC population mediates CD8
+ T cell activation.
To assess the role of DCs in the generation of neutralizing
antibodies against F-MLV, we infected the bone marrow chimeras
with F-MLV and depleted DCs by injection of DT from day 21t o
day 14 post-infection. At 14 dpi, we harvested peripheral blood
from infected mice and isolated serum. We then measured the titer
of F-MLV–specific neutralizing antibodies in the serum by
determining the maximum dilution of serum that was still
sufficient to neutralize F-MLV infection of Mus Dunni cells in
tissue culture. In wild-type infected mice, neutralizing antibody
titers were typically between 40–160. Strikingly, in DC depleted
mice, neutralizing antibodies were undetectable, with titers,10
(Figure 4B). These results demonstrate that CD11c
+ DCs play an
essential role in the generation of F-MLV–specific neutralizing
antibodies, but are less important for CTL responses.
Figure 3. Dendritic cells are required for immune control of F-MLV infection. Lethally irradiated C57BL/6 mice that had been reconstituted
with wild-type (WT) or CD11c-DTR bone marrow were infected intravenously with F-MLV. DT was injected intraperitoneally into both wild-type and
CD11c-DTR mice every day from one day prior to infection until 14 days post-infection. At 14 days post-infection, spleens were harvested, the level of
DC depletion analyzed (A), and the number of viral foci per spleen and spleen weight were measured (B). Each bar is the average of seven mice for
each group. The data shown are representative of three independent experiments.
doi:10.1371/journal.ppat.1000298.g003
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Because F-MLV particles contain molecules such as ssRNA that
could activate TLR signaling, we reasoned that infection might be
detected via a TLR-dependent pathway. To test whether TLR
signaling was required for immune control of F-MLV, we infected
mice heterozygous or homozygous for a null Myd88 allele and
a n a l y z e dv i r u sl e v e l si nt h es p l e e n sa tv a r i o u st i m e - p o i n t sp o s t -
infection. We also compared wild-type mice to heterozygous mice at
several time-points over an eight week period and found no
significant difference in viral titers, so all comparisons in subsequent
studies were between heterozygous and homozygous mutant mice. In
the first 7 days after infection, viral levels were slightly higher in
Myd88 null mice than in heterozygotes, but they reached a similar
peak level at one week post-infection (wpi). At two wpi, however, viral
titers were dramatically higher in Myd88 knockout mice. In
heterozygous mice, titers dropped to between 10
2 and 10
3 foci per
spleen, whereas in Myd88 knockout mice virus titers remained at
between 10
5 and10
6 foci per spleen. Furthermore, at 8 wpi and 16
wpi,heterozygousmicehaddevelopedalowlevelchronicinfectionat
10
2–10
3 foci per spleen, while Myd88 knockout mice exhibited high
(10
6–10
7 foci per spleen) levels of virus infection (Figure 5A). This
suggested that some aspect of immune control of F-MLV is impaired
in the absence of Myd88. In contrast with DC depletion,
splenomegaly was not enhanced relative to that in heterozygous
m i c ea t2w p i .B y1 6w p i ,h o w e v e r ,s o m eM y d 8 8k n o c k o u tm i c e
exhibited significantly enlarged spleens (Figure 5B). Interestingly,
M y d 8 8k n o c k o u tmi c ed i dn o tsh o was i g n if i c a n ti n c r e a s ei nm o r t a l i t y
relative to heterozygous mice over 16 weeks of infection, and infected
knockout mice seemed otherwise healthy despite maintaining high
virus titers (Figure 5C).
Figure 4. Dendritic cells are required for the neutralizing antibody response to F-MLV. (A) In dendritic cell-depleted F-MLV–infected mice,
the CD8
+ T cell response to F-MLV at 14 dpi was measured by staining splenocytes with the D
b-GagL tetramer. Representative FACS plots of D
bGagL
staining gated on CD8
+ cells are shown on the left. The proportion of CD8
+ T cells that stained with GagL was calculated for each sample and is
shown on the right. Each bar represents the average value of four mice. (B) In dendritic cell-depleted F-MLV–infected mice, the titer of F-MLV–
neutralizing antibodies in the serum was measured. Numerical values represent the maximum dilution of serum that neutralized F-MLV infection of
Mus Dunni cells. Each dot represents an individual mouse. The data shown are representative of three independent experiments.
doi:10.1371/journal.ppat.1000298.g004
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We had previously observed that the three major DC subsets in
the spleen undergo maturation between 7 and 10 days post-
infection. To determine if DC maturation was dependent on
Myd88, we analyzed expression of CD80 at 7 dpi on splenic DCs
of Myd88 heterozygous or knockout mice that had been infected
with F-MLV. As shown earlier (Figure 2), F-MLV infection caused
up-regulation of CD80 on all three major splenic DC subsets in
heterozygous mice. In the Myd88 knockout mice, the CD11c
+
B220
2 CD8a
2 DCs exhibited little reduction in up-regulation of
CD80 (Figure 6, left panel). CD11c
+ B220
2 CD8a
+ DCs and
CD11c
int B220
+ CD8a
2 DCs, by contrast, exhibited more
pronounced reduction in maturation, but still exhibited some
response to F-MLV (Figure 6, middle and right panels). This
suggests that both Myd88-dependent and independent pathways
contribute to the maturation of DCs in response to F-MLV, and
that the contribution made by Myd88-dependent signaling varies
somewhat between different DC subsets.
CD8
+ and CD4
+ T cell responses to F-MLV are present but
reduced in the absence of Myd88
Previous studies have shown that immune control of F-MLV
infectiondependsonallthree ofthe majorlymphocytepopulations-
CD4
+ T cells, CD8
+ T cells and B cells [24]. We wished to
determine if T cell responses to F-MLV were defective in Myd88
knockout mice. We infected Myd88 heterozygous and homozygous
mutant mice with F-MLV, and at 13 dpi analyzed CD8 T cells by
staining with the D
b-GagL tetramer (Figure 7A). In heterozygous
mice, approximately 5–8% of the CD8
+ T cell population stained
positive with this tetramer (Figure 7A, left panel). In naı ¨ve mice,
CD8 cells were not significantly stained (0.2%). In homozygous
mutant mice, the proportion of CD8
+ T cells that was D
b-GagL
+
was significantly reduced to approximately 2% (Figure 7A, right
panel). This indicates that the CD8
+ T cell response to F-MLV is
partially dependent on Myd88 signaling, but that Myd88-
independent mechanisms can compensate in its absence.
To determine if the CD4
+ T cell response to F-MLV was affected
by loss of Myd88, we analyzed CD4
+ T cells in infected Myd88
heterozygous or homozygous mutant mice by intracellular staining
for interferon-gamma (IFNc) expression. In naı ¨ve heterozygous and
knockout mice, roughly 3% of the CD4
+ T cells stained positive for
IFNc (Figure 7B). In infected heterozygous mice, 11% of the CD4
+
T cells were IFNc positive, indicative of a robust Th1 response to F-
MLV. By contrast, the proportion of IFNc positive CD4 T cells in
Myd88 knockout mice was reduced to 6%. These results indicate
that both the CD8
+ and CD4
+ T cell responses to F-MLV are
present but reduced in the absence of Myd88.
Myd88 is required for the generation of neutralizing
antibodies to F-MLV
To determine whether the B cell/antibody response to F-MLV
was affected by loss of Myd88, we measured the titer of F-MLV–
Figure 5. Myd88 is required for immune control of F-MLV. Myd88 knockout mice and heterozygous littermates were infected with F-MLV. (A)
At the times indicated, the viral titer in the spleen was measured. Each bar is the average of 4–8 mice. (B) At the times indicated, the weight of the
spleen was measured. Each bar is the average of 4–8 mice. (C) The survival of Myd88 knockout mice and heterozygous littermates was measured over
a 16-week period. The data shown are representative of two independent experiments.
doi:10.1371/journal.ppat.1000298.g005
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mice. At 14 dpi, heterozygous control mice exhibited a strong
neutralizing antibody response to F-MLV with a titer typically in
the range of 80 (Figure 8, upper panel). By contrast, in the serum
of Myd88-deficient mice, neutralizing antibodies were undetect-
able. We also measured neutralizing antibody titers at eight weeks
post-infection (Figure 8, lower panel), and found strong antibody
titers in the serum of heterozygous mice but undetectable F-MLV–
neutralizing activity in the homozygous mutant animals. Since it is
known that B cells and neutralizing antibodies are required to
control F-MLV, the results suggest that the lack of a neutralizing
antibody response is a significant contributor to the failure of
Myd88-deficient mice to control F-MLV.
F-MLV–specific IgG is absent from serum of infected mice
lacking Myd88 or CD11c
+ DCs
The absence of a detectable neutralizing antibody titer in
Myd88-deficient or CD11c
+ DC-deleted mice could reflect a
general loss of serum antibodies to F-MLV or a defect specifically
in antibodies that neutralize infection. To distinguish between
these possibilities, we measured F-MLV–specific IgG levels in the
serum of these mice at 14 dpi. F-MLV–specific antibodies were
detected by incubating serum samples from infected mice with a
suspension of an F-MLV–infected cell line, followed by staining for
mouse IgG and flow cytometry. Staining activity was present in
the serum of infected wild-type or Myd88 heterozygous mice, but
absent from the serum of naı ¨ve mice (Figure 9). Also, serum from
wild-type or Myd88 heterozygous mice did not stain an uninfected
cell line, indicating that the staining was specific for F-MLV (not
shown). Significantly, F-MLV–specific IgG was completely absent
from the serum of infected Myd88-deficient or DC-depleted mice.
These data argue that Myd88 and CD11c
+ DCs regulate the
generation of total anti F-MLV IgG levels, and not only the
amount of antibodies that neutralize viral infection.
Since B cells, CD4
+ T cells, and DCs are all known to regulate
antibody responses, it is possible that an increased level of viral
infection of one of these cell types during the acute phase was
responsible for the antibody defect in Myd88-deficient mice. To
examine this possibility, we examined the proportion of each of
these cells that was infected with F-MLV at 6 dpi by staining
splenocytes of infected mice for cell surface expression of the viral
GlycoGag protein. Neither B cells, CD4
+ T cells, nor DCs
exhibited significantly higher proportions of infected cells in
Myd88 knockout mice at this timepoint (not shown).
Serum from wild-type infected mice can rescue control
of F-MLV in Myd88-deficient mice
Because the most profound defect associated with the poor
control of F-MLV infection in Myd88-deficient mice was the lack
of a neutralizing antibody response, we asked whether passive
transfer of immune serum from wild-type mice could rescue
control of F-MLV in the mutant mice. We infected Myd88
heterozygous or homozygous mutant mice with F-MLV, and at 7
dpi homozygous mice were injected intraperitoneally with 0.5 ml
of serum taken either from naı ¨ve C57BL/6 mice or from mice that
had been infected with F-MLV 14 days earlier. Consistent with
our previous observations, at 14 dpi heterozygous mice had low
numbers of viral foci in their spleens, while Myd88-deficient mice
exhibited approximately 1000-fold higher numbers of foci
(Figure 10). Knockout mice that had received naı ¨ve serum had
virus titers similar to untreated knockout mice. However, Myd88-
deficient mice that had received serum from wild-type F-MLV–
infected mice had virus levels that were more than 100-fold lower,
with approximately 10
3 foci per spleen. This indicates that serum
Figure 6. Dendritic cell maturation during F-MLV infection is partially dependent on Myd88. Myd88 knockout mice and heterozygous
littermates were infected with F-MLV. At 7 dpi, splenic DCs were stained for expression of CD80. The populations were gated as follows: CD11c
+
B220
2 CD8a
2, CD11c
+ B220- CD8a
+, and CD11c
int, B220
+ CD8a
+. A representative histogram of CD80 staining from three independent experiments
using 4–6 mice is shown for each population.
doi:10.1371/journal.ppat.1000298.g006
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Myd88-deficient mice, and is consistent with the finding that the
most important role of Myd88 in F-MLV infection is the
generation of a virus-specific neutralizing antibody response.
Discussion
Although innate immune detection of viral pathogens is
considered to be important for the initiation of adaptive immune
responses, for most viruses, including retroviruses, the specific
sensing pathway has not been identified. Our results demonstrate
a crucial role for CD11c
+ DCs and Toll-like receptor signaling in
the antibody response to retroviral infection. We have also
identified a significant but less critical role for TLRs in CD4
+ and
CD8
+ T cell responses to retroviral infection. Myd88-deficient
mice sustain high titers of F-MLV for several months post-
infection, indicating that the response is not simply delayed. To
our knowledge, this is the first report of Myd88 or TLR signaling
playing an essential role in immune control of a virus that is
primarily mediated via the anti-viral antibody response. Similarly,
previous studies of the effect of DC depletion in immune control of
pathogens have focused on T cell responses, rather than on
antibody-mediated control [23,25]. Our results demonstrate that
depletion of DCs leads to a loss of immune control of F-MLV, and
this was found to coincide with a complete loss of F-MLV–specific
IgG but no significant reduction in CD8
+ T cells responses.
TheroleofTLRsinBcelldependentimmuneresponseshasbeen
somewhat controversial. Pasare and Medzhitov found that Myd88
knockout mice were defective at generating antibodies specific for
the model antigens OVA and HSA in the presence of LPS [26].
Furthermore, they found this defect to be at least partly B cell
intrinsic, since mice lacking mature B cells due to a disruption of the
Ig m chain (mMT mice) that had received B cells lacking Myd88, but
not mice that had received wild-type B cells, also had defective
antibody responses. This view has been challenged by Gavin and
coworkers [27] who found that Myd88
2/2;Trif
LPS2/LPS2 mice were
able to mount apparently normal antibody responses to the model
antigen trinitrophenol-hemocyanin given in complete Freund’s
adjuvant. However, neither of these studies examined the
requirement of TLR signaling for an antibody response in the
context of a live viral infection, nor did they examine the ability of
the antibody response to neutralize an infectious pathogen. The
issue of whether or not TLR signaling is important for effective
neutralizing antibody responses is of profound importance for
vaccine design, and the work that we describe here strongly suggests
that, for retroviral pathogens, functional TLR signaling is indeed
required for the antibody response.
Some previous reports have indicated a role for TLRs in the
development of antibody responses during viral infection. Heer and
coworkers found that, in Myd88 knockout mice, antibodies specific
for influenza exhibited defective class switching [28]. Furthermore,
it has been shown that long term maintenance of antibodies to
Figure 7. T cell responses to F-MLV are partially dependent on Myd88. Myd88 knockout mice and heterozygous littermates were infected
with F-MLV for 14 days. (A) Splenocytes were stained with TCRb, CD8a, and the D
bGagL tetramer, and the proportion of TCRb
+ CD8
+ cells that were
GagL
+ was measured. A representative FACS plot gated on TCRb
+ CD8
+ cells is shown in the upper panel. For the bar graph in the lower panel, each
bar is the average of four mice. (B) Splenocytes were stained for TCRb, CD4, and intracellular interferon-c. The proportion of TCRb
+ CD4
+ T cells that
expressed interferon-c was measured. Each bar is the average of four mice. The data shown are representative of three independent experiments.
doi:10.1371/journal.ppat.1000298.g007
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were still able to control polyoma virus infection in vivo [29].
Interestingly, Myd88-deficient mice that were infected with
Vesicular Stomatitis Virus exhibited higher levels of VSV-specific
IgG1 but lower levels of IgG2a relative to wild type mice, while the
neutralizing antibody titer was somewhat lower [30,31].
Previous studies of the roles played by TLRs in anti-viral immune
responses have shown significant differences from virus to virus. For
example, Myd88 is required for the CD8
+ T cell response to the
arenavirus LCMV [32,33], but not for the CD8
+ T cell response to
influenza[28].Thereasonforthe differential requirement forTLRs
in the immune response to different viruses is not clear but could be
related to the structural features of the virus, cell tropism, or the
details of the replication strategy used by the virus.
The specific cell type(s) in which TLR signaling is required for the
antibody response to F-MLV is not clear. TLR signaling in DCs
promotes the expression of costimulatory molecules such as CD80
and CD86 that are important for triggering CD4
+ and CD8
+ Tc e l l
responses. CD4
+ T cells, in turn, play an important role in activating
B cells.Thus,theeffect of DCsand TLR signaling on Bcellresponses
could be mediated through CD4
+ T cells. However, upregulation of
CD80 on the DC population (CD11c+,B 2 2 0 2,C D 8 a2)t h a ti s
known to control CD4
+ T cell responses was only slightly reduced in
theabsenceofMyd88. Similarly, the CD4
+T cell responsetoF-MLV
was reduced but not absent in Myd88 knockout mice. DCs are
known to activate B cells directly in a T cell independent manner by
FccRIIB-mediated recycling of whole antigen, but this process is not
known to be TLR dependent [34]. It is possible that DCs release
cytokines in a Myd88-dependent manner that directly affects B cell
responses. Also, since B cells express TLRs [35], it is possible that
TLR signaling is directly required in B cells to generate F-MLV–
specific antibodies. Conditional deletion of Myd88 in DCs or B cells
would address the relative contribution of Myd88-dependent
signaling in these cell types.
These results also suggest that DC-independent and Myd88-
independent pathways contribute to the development of the T cell
responses. Since retroviral genomes fold into structures that
contain dsRNA, it is possible that TLR3 and TRIF could be
involved. Also, since the retroviral replication cycle involves the
generation of dsDNA in the cytoplasm of infected cells, it its
possible that a cytoplasmic DNA sensor such as DAI contributes to
retroviral detection [36]. Cellular molecules that are released from
damaged cells, such as uric acid and ATP, have also been shown
to have the ability to stimulate immune responses [37], but most
retroviruses, including F-MLV, are non-cytopathic and do not
cause the death of infected cells.
Since DC-depleted mice can still mount a significant CD8
+ T
cell response to F-MLV, it is possible that another antigen
presenting cell type is sufficient to mediate this function. Depletion
of other antigen presenting cells such as B cells and macrophages
could be used to address this issue, although B cell-deficient mMT
mice are still able to mount a CD8
+ T cell response to F-MLV,
indicating that an essential role for B cells in the CD8 T cell
response is unlikely [38].
Could manipulation of TLR signaling potentially be used to
enhance effectiveness of an HIV vaccine? It has been argued that
effective vaccines, such as live attenuated vaccines, are able to provide
effective protection because they stimulate TLRs. Furthermore, most
effective vaccines involve the use of adjuvants that contain TLR
ligands, although for many of these the role of TLR signaling has not
been conclusively demonstrated. One study found that administra-
tion of the TLR9 ligand CpG enhanced the cellular and humoral
response induced by a Gag prime boost vaccine [39]. Also, ithas been
demonstrated that conjugating Gag to the TLR7 agonist R-848
Figure 8. Myd88 is required for a neutralizing antibody response against F-MLV. Serum was isolated from the peripheral blood of F-MLV–
infected Myd88
2/2 and Myd88
+/2 littermate controls at 2 wpi and 8 wpi. The titer of neutralizing antibodies in the serum was measured. Each dot
represents an individual mouse. The data shown are from one of four independent experiments.
doi:10.1371/journal.ppat.1000298.g008
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remains to be determined, however, whether either of these
approaches will enhance protection from HIV infection.
B cell vaccines and T cell vaccines have by themselves been
unsuccessful in eliciting protection from HIV infection. For F-
MLV, Messer and coworkers found that neither vaccination with
the cell line FBL3 that expresses the viral protein GlycoGag to
stimulate T cell responses nor passive transfer of neutralizing
antibodies is sufficient to elicit sterilizing immunity [38]. However,
the combination of immune serum and the FBL3 T cell vaccine
did result in sterilizing immunity.
The issue of why HIV infected patients fail to develop an
effective neutralizing antibody response remains unresolved. If
TLR signaling is involved in the antibody response to HIV, it is
conceivable that viral disruption of TLR signaling could
contribute to the failure of this response. However, virus specific
antibodies are not absent in HIV infected persons, but they lack
sufficient neutralizing activity to control the viremia [41]. Our
findings indicate that Myd88 plays a fundamental role in the
generation of a total retroviral antibody response rather than
specifically neutralizing antibodies.
In summary, these results demonstrate a critical role for DCs
and TLR signaling in the humoral immune response to retroviral
infection, and provide the first in vivo examination of the role
played by TLRs in immune control of retroviral pathogens.
Understanding precisely how TLR signaling contributes to the
anti-retroviral immune response will help to guide the develop-
ment of vaccines for retroviral pathogens such as HIV.
Materials and Methods
Mice
Wild-type C57BL/6 mice were obtained from Taconic Farms.
Myd88-deficient mice were a gift from R. Medzhitov and were
backcrossed to the C57BL/6 background for 5 generations. The
Myd88-deficient mice were originally developed in the laboratory
of S. Akira (Osaka, Japan). For all experiments, littermate controls
were used. CD11c-DTR mice have been previously described
Figure 9. F-MLV–specific IgG is absent from serum of infected mice lacking Myd88 or CD11c
+ DCs. Serum samples from naı ¨ve or infected
mice were assayed for the presence of F-MLV–specific IgG, by incubation with a suspension of F-MLV–infected cells, followed by secondary staining
for mouse IgG. The cells were then analyzed by flow cytometry. Representative stainings for Myd88 knockout mice (upper left) and CD11c
+ DC-
depleted mice (upper right) are shown. Mean fluorescence intensities (MFI) for the average of five mice were calculated for each condition and
plotted (lower panel). The data shown are from one of two independent experiments.
doi:10.1371/journal.ppat.1000298.g009
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approval for mouse experiments was obtained from the NYU
Medical Center Institutional Animal Care and Use Committee.
Viral infections
F-MLV stocks were generated by infection of Balb/c mice with
5000 focus-forming units of F-MLV. At 14 dpi, a 10% spleen
homogenate suspension was made and titered by focus-forming
assay. For experiments, mice at 6–8 weeks of age were infected
with 7000 focus-forming units of F-MLV by retro-orbital
intravenous injection.
Focus-forming assays
Splenocytes in suspension were serially diluted and plated on a
subconfluent monolayer of the F-MLV–susceptible Mus Dunni cell
line. For platings, 5610
1–5610
6 splenocytes were added to 2610
5
Mus Dunni cells in 6 well plates. After 3 days of co-culture in RPMI
medium, the cells were fixed with methanol and stained for
2 hours with the monoclonal antibody mAb720, which recognizes
the F-MLV envelope glycoprotein. The cells were washed three
times with phosphate-buffered saline and stained with anti-mouse
IgG1 horseradish peroxidase for one hour. Foci were then
visualized by adding Amino ethyl Carbazole/Hydrogen peroxide
substrate (Sigma).
Bone marrow chimeras and CD11c
+ DC depletions
Wild-type C57BL/6 mice at 6–8 weeks of age were lethally
irradiated with two doses of 550 Rads separated by six hours and
then injected intravenously with bone marrow cells from wild-type
or CDllc-DTR transgenic mice. The chimeras were then kept for
6 weeks to permit engraftment of donor bone marrow. During this
period, the mice were supplied with antibiotics in their drinking
water to prevent infection. Depletion of CD11c
+ dendritic cells
was carried out by fifteen days of daily intraperitoneal injection of
200 ng of diphtheria toxin (Sigma).
Intracellular cytokine staining
Splenocytes were plated in RPMI containing 50 ng/mL PMA
and 1 uM ionomycin plus GolgiStop (BD Biosciences). After 3 h
stimulation, cells were washed in PBS and stained for cell surface
markers. The cells were then washed in PBS and resuspended in
permeabilization-fixing buffer (BD Biosciences). After incubation
at 4uC for 45 minutes, the cells were washed and resuspended in
permeabilization/wash buffer containing anti-IFNc-PE antibody.
Staining was carried out at for 45–60 min at 4uC. Finally, the cells
were washed in 1–2 mL BD perm/wash buffer and resuspended
in PBS for analysis.
Neutralizing antibody titers
To measure neutralizing antibody titers in infected mice,
peripheral blood was obtained by retro-orbital bleed, and serum
extracted by centrifugation. The serum was diluted in a two-fold
dilution series, and mixed with an F-MLV sample before plating
on Mus Dunni cells. Three days later, when the Mus Dunni cells
were confluent, infected foci were visualized. The neutralizing
antibody titer was defined as the maximum serum dilution that
reduced the number of F-MLV foci by at least 75%.
F-MLV–specific IgG assay
Serum samples from infected or naı ¨ve mice were diluted in
phosphate buffer saline with 2% fetal bovine serum. Samples were
then incubated with a suspension of the chronically F-MLV–infected
cell line NRK/SFFV-57 on ice for 45 minutes to capture F-MLV–
specific antibodies. 100,000 cells were used per staining. The cells
were then washed twice and resuspended in PBS/FBS. Secondary
staining using Allophycocyanin-conjugated anti-mouse IgG (eBios-
ciences) was performed, then the cells were analyzed by flow
cytometry.
Statistical analysis
To determine statistical significance, P values for specific
experiments were calculated using the Student’s T- test for
Figures 3B, 4A, and 7, and by Mann-Whitney test for Figures 3A,
4B, 8, and 10.
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Figure 10. Transfer of serum from infected wild-type mice to
Myd88 knockout mice rescues control of F-MLV. Myd88
knockout mice or heterozygous littermates were infected with F-MLV.
At 7 dpi, infected mice were injected intraperitoneally with 0.5 ml
serum from uninfected C57BL/6 mice or from C57BL/6 mice that had
been infected with F-MLV for 14 days. At 14 dpi, the levels of viral focus-
forming units in the spleens of infected mice were analyzed. Each bar
represents the average of 4–7 mice from one of two independent
experiments.
doi:10.1371/journal.ppat.1000298.g010
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